ALDH1A1 and breast cancer: Patients with IIA–IIIB (T1-4N0-3M0), triple negative BC, and HER+ BC, are divided into a group with a significant number of ALDH1+ cells and a group with a small number of ALDH1+ cells in the blood and tumors.